Close Menu

NEW YORK – Genomics analysis firm ArcherDx has filed a regulatory document with the US Securities and Exchange Commission to go public with plans to raise up to $100 million.

The Boulder, Colorado-based company has not priced the offering or said how many shares it expects to offer in its Form S-1 filed on Friday. JP Morgan, Bank of America Securities, Stiffel, and Evercore ISI are listed as the proposed offering's underwriters. ArcherDx plans to list its stock on the Nasdaq under ticker symbol "RCHR".

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.